Adam M Marcetich
Examiner (ID: 16473, Phone: (571)272-2590 , Office: P/3761 )
Most Active Art Unit | 3761 |
Art Unit(s) | 3781, 3761 |
Total Applications | 1415 |
Issued Applications | 890 |
Pending Applications | 99 |
Abandoned Applications | 426 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 3656805
[patent_doc_number] => 05622932
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'IGF-1 superagonists'
[patent_app_type] => 1
[patent_app_number] => 8/435252
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8176
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622932.pdf
[firstpage_image] =>[orig_patent_app_number] => 435252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435252 | IGF-1 superagonists | May 4, 1995 | Issued |
Array
(
[id] => 3536635
[patent_doc_number] => 05480640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-02
[patent_title] => 'Alpha interferon for treating prostate cancer'
[patent_app_type] => 1
[patent_app_number] => 8/432742
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2075
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/480/05480640.pdf
[firstpage_image] =>[orig_patent_app_number] => 432742
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432742 | Alpha interferon for treating prostate cancer | May 1, 1995 | Issued |
Array
(
[id] => 3590181
[patent_doc_number] => 05567679
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-22
[patent_title] => 'Use of CGRP in treating alopecia'
[patent_app_type] => 1
[patent_app_number] => 8/430505
[patent_app_country] => US
[patent_app_date] => 1995-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1554
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/567/05567679.pdf
[firstpage_image] =>[orig_patent_app_number] => 430505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/430505 | Use of CGRP in treating alopecia | Apr 27, 1995 | Issued |
08/387944 | WOUND HEALING REMEDY | Apr 9, 1995 | Abandoned |
08/418341 | CYCLIC PEPTIDE ANTIFUNGAL AGENTS | Apr 6, 1995 | Abandoned |
Array
(
[id] => 3612233
[patent_doc_number] => 05565423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-15
[patent_title] => 'Cyclopeptides and their use as absorption promoters when applied to the mucosa'
[patent_app_type] => 1
[patent_app_number] => 8/418882
[patent_app_country] => US
[patent_app_date] => 1995-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3969
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/565/05565423.pdf
[firstpage_image] =>[orig_patent_app_number] => 418882
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418882 | Cyclopeptides and their use as absorption promoters when applied to the mucosa | Apr 6, 1995 | Issued |
Array
(
[id] => 3555339
[patent_doc_number] => 05543392
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Digestive tract cell activating agent of EGF and lactoferrin'
[patent_app_type] => 1
[patent_app_number] => 8/374785
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4979
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543392.pdf
[firstpage_image] =>[orig_patent_app_number] => 374785
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/374785 | Digestive tract cell activating agent of EGF and lactoferrin | Apr 2, 1995 | Issued |
Array
(
[id] => 3516729
[patent_doc_number] => 05486465
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-23
[patent_title] => 'Teicoplanin recovery process'
[patent_app_type] => 1
[patent_app_number] => 8/413971
[patent_app_country] => US
[patent_app_date] => 1995-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2892
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/486/05486465.pdf
[firstpage_image] =>[orig_patent_app_number] => 413971
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/413971 | Teicoplanin recovery process | Mar 28, 1995 | Issued |
Array
(
[id] => 3603386
[patent_doc_number] => 05533836
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Compositions and methods for stimulating the growth of osteoblasts'
[patent_app_type] => 1
[patent_app_number] => 8/408331
[patent_app_country] => US
[patent_app_date] => 1995-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7827
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/533/05533836.pdf
[firstpage_image] =>[orig_patent_app_number] => 408331
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408331 | Compositions and methods for stimulating the growth of osteoblasts | Mar 21, 1995 | Issued |
Array
(
[id] => 3590302
[patent_doc_number] => 05516889
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-14
[patent_title] => 'Synthetic thrombin receptor peptides'
[patent_app_type] => 1
[patent_app_number] => 8/405933
[patent_app_country] => US
[patent_app_date] => 1995-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 14814
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/516/05516889.pdf
[firstpage_image] =>[orig_patent_app_number] => 405933
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/405933 | Synthetic thrombin receptor peptides | Mar 16, 1995 | Issued |
Array
(
[id] => 3485717
[patent_doc_number] => 05470566
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-28
[patent_title] => 'Solid oral anticariogenic composition'
[patent_app_type] => 1
[patent_app_number] => 8/402774
[patent_app_country] => US
[patent_app_date] => 1995-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6496
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/470/05470566.pdf
[firstpage_image] =>[orig_patent_app_number] => 402774
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/402774 | Solid oral anticariogenic composition | Mar 8, 1995 | Issued |
Array
(
[id] => 3588885
[patent_doc_number] => 05552521
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Process for preparing certain aza cyclohexapeptides'
[patent_app_type] => 1
[patent_app_number] => 8/386618
[patent_app_country] => US
[patent_app_date] => 1995-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2351
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552521.pdf
[firstpage_image] =>[orig_patent_app_number] => 386618
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/386618 | Process for preparing certain aza cyclohexapeptides | Feb 9, 1995 | Issued |
Array
(
[id] => 3550409
[patent_doc_number] => 05547938
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Therapeutic agent for digestive tract diseases using glicentin'
[patent_app_type] => 1
[patent_app_number] => 8/377833
[patent_app_country] => US
[patent_app_date] => 1995-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4716
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547938.pdf
[firstpage_image] =>[orig_patent_app_number] => 377833
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/377833 | Therapeutic agent for digestive tract diseases using glicentin | Jan 24, 1995 | Issued |
Array
(
[id] => 3117250
[patent_doc_number] => 05449748
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-12
[patent_title] => 'Preparation of anhydropolyamino acids at temperatures of 350.degree. C. or above'
[patent_app_type] => 1
[patent_app_number] => 8/364633
[patent_app_country] => US
[patent_app_date] => 1994-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1502
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/449/05449748.pdf
[firstpage_image] =>[orig_patent_app_number] => 364633
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/364633 | Preparation of anhydropolyamino acids at temperatures of 350.degree. C. or above | Dec 26, 1994 | Issued |
Array
(
[id] => 3621506
[patent_doc_number] => 05620685
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Protecting agents from radiation hazards'
[patent_app_type] => 1
[patent_app_number] => 8/357125
[patent_app_country] => US
[patent_app_date] => 1994-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620685.pdf
[firstpage_image] =>[orig_patent_app_number] => 357125
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/357125 | Protecting agents from radiation hazards | Dec 15, 1994 | Issued |
Array
(
[id] => 3526335
[patent_doc_number] => 05541159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Calcitonin derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/346118
[patent_app_country] => US
[patent_app_date] => 1994-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13357
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541159.pdf
[firstpage_image] =>[orig_patent_app_number] => 346118
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/346118 | Calcitonin derivatives | Nov 28, 1994 | Issued |
Array
(
[id] => 3538767
[patent_doc_number] => 05494893
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-02-27
[patent_title] => 'Stylostatin 2'
[patent_app_type] => 1
[patent_app_number] => 8/338384
[patent_app_country] => US
[patent_app_date] => 1994-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7757
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/494/05494893.pdf
[firstpage_image] =>[orig_patent_app_number] => 338384
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338384 | Stylostatin 2 | Nov 13, 1994 | Issued |
Array
(
[id] => 3553666
[patent_doc_number] => 05518999
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'Method for treating Kaposi\'s sarcoma and blocking or inhibiting vascular permeability'
[patent_app_type] => 1
[patent_app_number] => 8/336612
[patent_app_country] => US
[patent_app_date] => 1994-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 22
[patent_no_of_words] => 6836
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/518/05518999.pdf
[firstpage_image] =>[orig_patent_app_number] => 336612
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/336612 | Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability | Nov 8, 1994 | Issued |
08/317422 | TEICOPLANIN RECOVERY PROCESS | Oct 3, 1994 | Abandoned |
Array
(
[id] => 3463534
[patent_doc_number] => 05468843
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'Acetic anhydride activation for C-terminal protein sequencing'
[patent_app_type] => 1
[patent_app_number] => 8/302154
[patent_app_country] => US
[patent_app_date] => 1994-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 37
[patent_no_of_words] => 4753
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468843.pdf
[firstpage_image] =>[orig_patent_app_number] => 302154
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/302154 | Acetic anhydride activation for C-terminal protein sequencing | Sep 7, 1994 | Issued |